275 related articles for article (PubMed ID: 33939897)
1. Effect of l-carnitine supplementation on children and adolescents with nonalcoholic fatty liver disease (NAFLD): a randomized, triple-blind, placebo-controlled clinical trial.
Saneian H; Khalilian L; Heidari-Beni M; Khademian M; Famouri F; Nasri P; Hassanzadeh A; Kelishadi R
J Pediatr Endocrinol Metab; 2021 Jul; 34(7):897-904. PubMed ID: 33939897
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 Fatty acids therapy in children with nonalcoholic Fatty liver disease: a randomized controlled trial.
Janczyk W; Lebensztejn D; Wierzbicka-Rucińska A; Mazur A; Neuhoff-Murawska J; Matusik P; Socha P
J Pediatr; 2015 Jun; 166(6):1358-63.e1-3. PubMed ID: 25771388
[TBL] [Abstract][Full Text] [Related]
3. Hepatoprotective effect of combination of L-carnitine and magnesium-hydroxide in nonalcoholic fatty liver disease patients: a double-blinded randomized controlled pilot study.
Hazzan R; Abu Ahmad N; Slim W; Mazen E; Neeman Z
Eur Rev Med Pharmacol Sci; 2022 Oct; 26(20):7522-7532. PubMed ID: 36314323
[TBL] [Abstract][Full Text] [Related]
4. In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores.
Schwimmer JB; Lavine JE; Wilson LA; Neuschwander-Tetri BA; Xanthakos SA; Kohli R; Barlow SE; Vos MB; Karpen SJ; Molleston JP; Whitington PF; Rosenthal P; Jain AK; Murray KF; Brunt EM; Kleiner DE; Van Natta ML; Clark JM; Tonascia J; Doo E;
Gastroenterology; 2016 Dec; 151(6):1141-1154.e9. PubMed ID: 27569726
[TBL] [Abstract][Full Text] [Related]
5. Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress.
Farhangi MA; Alipour B; Jafarvand E; Khoshbaten M
Arch Med Res; 2014 Oct; 45(7):589-95. PubMed ID: 25450583
[TBL] [Abstract][Full Text] [Related]
6. Effect of sour tea supplementation on liver enzymes, lipid profile, blood pressure, and antioxidant status in patients with non-alcoholic fatty liver disease: A double-blind randomized controlled clinical trial.
Izadi F; Farrokhzad A; Tamizifar B; Tarrahi MJ; Entezari MH
Phytother Res; 2021 Jan; 35(1):477-485. PubMed ID: 32909326
[TBL] [Abstract][Full Text] [Related]
7. The Importance of the Fatty Acid Transporter L-Carnitine in Non-Alcoholic Fatty Liver Disease (NAFLD).
Savic D; Hodson L; Neubauer S; Pavlides M
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32708036
[TBL] [Abstract][Full Text] [Related]
8. Does turmeric/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta-analysis of randomized controlled trials.
Goodarzi R; Sabzian K; Shishehbor F; Mansoori A
Phytother Res; 2019 Mar; 33(3):561-570. PubMed ID: 30653773
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Treatment with n-3 Polyunsaturated Fatty Acids as a Monotherapy in Children with Nonalcoholic Fatty Liver Disease.
Boyraz M; Pirgon Ö; Dündar B; Çekmez F; Hatipoğlu N
J Clin Res Pediatr Endocrinol; 2015 Jun; 7(2):121-7. PubMed ID: 26316434
[TBL] [Abstract][Full Text] [Related]
10. Effects of carnitine supplementation on liver aminotransferase enzymes: A systematic review and meta-analysis of randomized controlled clinical trials.
Yousefi Rad E; Eslampour E; Falahi E; Mardani M; Hekmatdoost A; Asbaghi O; Saboori S
Indian J Gastroenterol; 2019 Dec; 38(6):470-479. PubMed ID: 31828538
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D and nonalcoholic fatty liver disease in children: a randomized controlled clinical trial.
El Amrousy D; Abdelhai D; Shawky D
Eur J Pediatr; 2022 Feb; 181(2):579-586. PubMed ID: 34459959
[TBL] [Abstract][Full Text] [Related]
12. Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Farsi F; Mohammadshahi M; Alavinejad P; Rezazadeh A; Zarei M; Engali KA
J Am Coll Nutr; 2016; 35(4):346-53. PubMed ID: 26156412
[TBL] [Abstract][Full Text] [Related]
13. Improvement of Nonalcoholic Fatty Liver Disease With Carnitine-Orotate Complex in Type 2 Diabetes (CORONA): A Randomized Controlled Trial.
Bae JC; Lee WY; Yoon KH; Park JY; Son HS; Han KA; Lee KW; Woo JT; Ju YC; Lee WJ; Cho YY; Lee MK
Diabetes Care; 2015 Jul; 38(7):1245-52. PubMed ID: 25877813
[TBL] [Abstract][Full Text] [Related]
14. The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
Abolfathi M; Mohd-Yusof BN; Hanipah ZN; Mohd Redzwan S; Yusof LM; Khosroshahi MZ
Complement Ther Med; 2020 Jan; 48():102273. PubMed ID: 31987257
[TBL] [Abstract][Full Text] [Related]
15. Sesame Oil Ameliorates Alanine Aminotransferase, Aspartate Aminotransferase, and Fatty Liver Grade in Women with Nonalcoholic Fatty Liver Disease Undergoing Low-Calorie Diet: A Randomized Double-Blind Controlled Trial.
Atefi M; Entezari MH; Vahedi H; Hassanzadeh A
Int J Clin Pract; 2022; 2022():4982080. PubMed ID: 35685535
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Phytosomal Curcumin in Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial.
Panahi Y; Kianpour P; Mohtashami R; Jafari R; Simental-Mendía LE; Sahebkar A
Drug Res (Stuttg); 2017 Apr; 67(4):244-251. PubMed ID: 28158893
[TBL] [Abstract][Full Text] [Related]
17. Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial.
Namkhah Z; Naeini F; Mahdi Rezayat S; Mehdi Yaseri ; Mansouri S; Javad Hosseinzadeh-Attar M
Int J Clin Pract; 2021 Nov; 75(11):e14852. PubMed ID: 34516703
[TBL] [Abstract][Full Text] [Related]
18. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial.
Lavine JE; Schwimmer JB; Van Natta ML; Molleston JP; Murray KF; Rosenthal P; Abrams SH; Scheimann AO; Sanyal AJ; Chalasani N; Tonascia J; Ünalp A; Clark JM; Brunt EM; Kleiner DE; Hoofnagle JH; Robuck PR;
JAMA; 2011 Apr; 305(16):1659-68. PubMed ID: 21521847
[TBL] [Abstract][Full Text] [Related]
19. Effects of Zinc Supplementation on Inflammatory Status and Nonalcoholic Steatohepatitis in Overweight or Obese Children: a Randomized Clinical Trial.
Ostadmohammadi V; Namazi MJ; Rezasoltani M; Kheirkhah D; Rajabi M; Sharif A; Taghavi Ardakani A; Raygan F; Assareh AA; Sharif MR
Biol Trace Elem Res; 2024 Aug; 202(8):3496-3503. PubMed ID: 37989929
[TBL] [Abstract][Full Text] [Related]
20. Treatment options for nonalcoholic fatty liver disease: a double-blinded randomized placebo-controlled trial.
Anushiravani A; Haddadi N; Pourfarmanbar M; Mohammadkarimi V
Eur J Gastroenterol Hepatol; 2019 May; 31(5):613-617. PubMed ID: 30920975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
